益智脑部补充剂市场－全球产业规模、份额、趋势、机会及预测（按益智药类型、剂型、成分类型、应用、销售管道、地区和竞争格局划分），2021-2031年

全球益智补脑产品市场预计将从2025年的95.1亿美元成长到2031年的146.5亿美元，复合年增长率（CAGR）为7.47%。益智补脑产品通常被称为“聪明药”或“认知增强剂”，是指健康人群服用以增强记忆力、创造力、动力和注意力等认知能力的天然或合成化合物。推动市场成长的主要因素包括：全球人口老化，人们希望延缓与老龄化相关的认知衰退；以及专业人士和学生为维持高效率而日益增长的需求。这些因素促使消费者持续依赖预防性脑健康策略，使该市场区别于昙花一现的健康趋势。

然而，该行业面临许多挑战，包括监管不明晰和健康声明检验，这些都可能削弱消费者信心并限制产品分销。美国植物委员会 (ABC) 发布的《2024 年草药市场报告》凸显了这一趋势，报告指出，用于认知增强的蘑菇补充剂的销售额预计将在 2024 年飙升 114.5%，达到 765 万美元。儘管成长迅速，但对临床疗效和标籤合规性的严格监管仍然是阻碍市场整体发展的主要障碍。

市场驱动因素

神经退化性疾病疾病和精神疾病发病率的上升正将市场从单纯的性能提升领域转变为预防医学的关键领域。随着全球人口老化，人们认知能力下降的风险日益增加，推动了对非药物解决方案的需求，以保护执行功能和记忆力。阿兹海默症协会发布的《2024年阿兹海默症事实与数据》报告强调了这一迫切需求，该报告估计，美国有690万65岁及以上的老年人患有老年痴呆症失智症。因此，製造商面临着开发靶向神经保护配方的压力，并将市场从健康成年人扩展到那些希望积极管理自身长期脑健康的人。

同时，电子竞技和游戏产业正崛起为一个盈利的市场，该市场非常重视反应速度、专注力和处理速度。与传统的运动营养产品不同，这些消费者需要专门设计的、能够增强认知功能的产品，以便在长时间的游戏过程中保持竞争优势。娱乐软体协会 (ESA) 发布的《2024 年美国电子游戏产业基础报告》也印证了游戏与认知能力维持之间的协同作用，该报告显示，37% 的玩家会透过玩游戏来保持思维敏捷。製造商们正积极响应这一趋势，推出面向游戏玩家的营养补充剂，并利用责任营养委员会 (Council for Responsible Nutrition) 在 2024 年指出的一个趋势：19% 的消费者表示，他们服用营养补充剂的主要动机是维护心理健康。

市场挑战

全球益智脑类补充剂市场面临的主要障碍是监管政策不明朗以及对健康声明的严格验证要求。监管机构对功效声明设定了严格的标准，这使得製造商在检验认知增强功效的同时，也要避免产品被错误地归类为药品，从而造成了巨大的挑战。这种监管不确定性减缓了产品创新，延缓了产品进入市场，因为企业必须严格遵守复杂的合规规则，以避免代价高昂的执法行动和强制产品召回。

因此，这些监管压力削弱了消费者信任，而消费者信任对于市场的持续成长至关重要。当标籤法规限制製造商明确宣称产品已证实的效益时，潜在客户往往会对产品的有效性产生怀疑。这种怀疑态度对一个重要且不断增长的消费群体构成了风险：根据责任营养委员会 (CRN) 2024 年的一份报告，19% 的膳食补充剂使用者将心理健康作为其健康管理的首要考虑因素。认知功效声明难以达到严格的证据标准，这可能会疏远这一大规模的消费群体，并可能阻碍预防性脑健康解决方案的广泛应用。

市场趋势

将认知支持成分融入女性健康产品正迅速成为一种显着趋势，其作用已从平衡激素扩展到治疗特定的神经系统问题，例如执行功能障碍和脑雾。製造商日益认识到，更年期过渡会对认知功能产生深远影响，而随着越来越多的女性在晚年继续从事高强度职业，这已成为一个重要问题。基于此，有些配方应运而生，将平衡荷尔蒙的适应原与促智药结合，以增强注意力和记忆力，从而使这些产品区别于普通综合维他命。 Bonafide Health 发布的《2024 年更年期状况报告》凸显了此类产品的需求，该报告发现，42% 的受访女性表示，更年期症状（包括认知障碍）对她们的职业抱负产生了负面影响。

同时，受片剂服用疲劳的普遍影响，以及消费者对能够无缝融入日常生活的服用方式的偏好，市场上的补充剂形式正呈现显着多样化。创新产品不再局限于软糖，而是扩展到液体补充剂、机能饮料和口腔喷雾剂等领域，这些产品具有服用方便、吸收迅速等优势。这些新形式尤其受到生物骇客和年轻消费者的青睐，他们除了关注认知提升之外，也重视产品的高效便捷。 The Vitamin Shoppe发布的《2024年健康与保健趋势报告》也印证了这些替代产品的商业性成功。报告指出，今年前四个月，创新、高生物有效性液体补充剂的销量成长了25%，超过了传统类别。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球益智脑部补充品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 益智药类型（天然益智药、合成益智药、混合益智药）
  • 按剂型（胶囊/锭剂、粉末、液体）
  • 依成分类型（吡拉西坦类药物、胆碱来源、草药萃取物、胺基酸、其他）
  • 使用方法（改善记忆力、专注力和专注力，改善情绪、精力和警觉性，改善睡眠，促进大脑健康，延年益寿）
  • 依销售管道（线上零售商、药局/药局、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美益智脑部补充品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲益智脑部补充品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区益智补脑产品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东及非洲益智药及脑部营养补充品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲益智脑部补充品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球益智脑部补充品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Onnit Labs, LLC
• Hudson Aquatic Systems LLC
• HVMN Inc.
• Peak Nootropics
• Nootropics Depot
• Pure Nootropics
• Mind Nutrition Ltd.
• Natural Stacks LLC
• Nootrobox
• Mind Lab Pro

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Nootropics Brain Supplements Market is projected to expand from USD 9.51 Billion in 2025 to USD 14.65 Billion by 2031, reflecting a compound annual growth rate of 7.47%. Commonly known as smart drugs or cognitive enhancers, nootropics are natural or synthetic compounds ingested by healthy individuals to boost mental capabilities like memory, creativity, motivation, and attention. Growth is primarily driven by a globally aging population aiming to delay age-associated cognitive deterioration and the escalating demands on professionals and students to sustain high productivity levels. These drivers set the market apart from fleeting wellness fads by creating a durable consumer dependency on preventative brain health strategies.

However, the sector encounters significant hurdles related to uncertain regulations and the verification of health claims, issues that can erode consumer confidence and restrict product availability. Data from the American Botanical Council's 2024 Herb Market Report highlights this dynamic, noting that sales of mushroom supplements for cognitive health surged by 114.5% in 2024, totaling $7.65 million. Despite this rapid growth, strict oversight from regulatory authorities concerning clinical efficacy and labeling compliance persists as a major barrier that threatens to slow widespread market development.

Market Driver

The rising incidence of neurodegenerative and mental health conditions is transforming the market from a niche for performance enhancement into a vital sector for preventative care. With aging populations worldwide facing elevated risks of cognitive decline, there is a growing demand for non-pharmaceutical solutions to maintain executive function and memory. This critical need is highlighted by the Alzheimer's Association's '2024 Alzheimer's Disease Facts and Figures', which estimates that 6.9 million Americans aged 65 and older suffer from Alzheimer's dementia. Consequently, manufacturers are impelled to create targeted neuroprotective formulations, thereby extending the market reach beyond healthy adults to include individuals proactively addressing long-term brain health.

Concurrently, the esports and gaming industry has emerged as a profitable demographic that values reaction time, focus, and processing speed. Unlike standard sports nutrition, these consumers require products specifically designed for cognitive outcomes to sustain a competitive edge during extended gaming sessions. This synergy between gaming and cognitive preservation is supported by the Entertainment Software Association's '2024 Essential Facts About the U.S. Video Game Industry', which reveals that 37% of players engage in gaming specifically to maintain mental sharpness. Manufacturers are responding with gamer-oriented supplements, capitalizing on a trend noted by the Council for Responsible Nutrition in 2024, where 19% of consumers identified mental health as a primary motivation for supplement use.

Market Challenge

A major obstacle confronting the Global Nootropics Brain Supplements Market is the lack of regulatory clarity and the stringent requirements for substantiating health claims. Regulatory agencies impose rigorous standards for efficacy assertions, creating a difficult environment where manufacturers struggle to verify cognitive enhancement benefits without inadvertently classifying their products as pharmaceuticals. This regulatory uncertainty slows product innovation and delays market entry, as companies must carefully navigate complex compliance rules to prevent expensive enforcement actions or mandatory product recalls.

As a result, these regulatory pressures erode consumer trust, which is essential for maintaining market growth. When labeling restrictions prevent manufacturers from clearly stating proven benefits, potential customers often doubt the product's effectiveness. This skepticism poses a risk to a vital and expanding consumer segment; the Council for Responsible Nutrition reported in 2024 that 19% of supplement users prioritize mental health in their regimen. The industry's difficulty in meeting rigorous evidentiary standards for cognitive claims threatens to alienate this large demographic, thereby hindering the broader acceptance of preventative brain health solutions.

Market Trends

The incorporation of cognitive support into women's health products is rapidly becoming a defining trend, evolving beyond hormonal balance to treat specific neurological issues such as executive dysfunction and brain fog. Manufacturers are increasingly acknowledging that the menopausal transition severely affects cognitive performance, a major concern for the growing number of women maintaining demanding careers later in life. This insight is driving the creation of formulations that blend hormone-balancing adaptogens with nootropics to support focus and memory, setting them apart from standard multivitamins. The necessity for these products is underscored by Bonafide Health's 'State of Menopause 2024' report, in which 42% of surveyed women indicated that menopausal symptoms, including cognitive disruption, negatively affected their career aspirations.

In parallel, the market is undergoing a significant diversification of delivery formats, spurred by widespread pill fatigue and a preference for consumption methods that integrate seamlessly into lifestyle routines. Innovation has expanded beyond gummies to include liquid shots, functional beverages, and oral sprays, which offer benefits like easier compliance and faster absorption. These novel formats are especially attractive to biohackers and younger demographics who value efficiency and convenience alongside cognitive enhancement. The commercial success of these alternatives is confirmed by The Vitamin Shoppe's 'Health & Wellness Trend Report 2024', which noted that sales of innovative, high-bioavailability liquid supplements rose by 25% in the first four months of the year, outpacing traditional categories.

Key Market Players

• Onnit Labs, LLC
• Hudson Aquatic Systems LLC
• HVMN Inc.
• Peak Nootropics
• Nootropics Depot
• Pure Nootropics
• Mind Nutrition Ltd.
• Natural Stacks LLC
• Nootrobox
• Mind Lab Pro

Report Scope

In this report, the Global Nootropics Brain Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nootropics Brain Supplements Market, By Type of Nootropics

• Natural Nootropics
• Synthetic Nootropics
• Hybrid Nootropics

Nootropics Brain Supplements Market, By Form

• Capsules/Tablets
• Powders
• Liquids

Nootropics Brain Supplements Market, By Ingredient Type

• Racetams
• Choline Sources
• Herbal Extracts
• Amino Acids
• Others

Nootropics Brain Supplements Market, By Application

• Memory Enhancement
• Focus and Concentration
• Mood Enhancement
• Energy and Alertness
• Sleep Improvement
• Brain Health
• Longevity

Nootropics Brain Supplements Market, By Sales Channel

• Online Retailers
• Drugstores and Pharmacies
• Others

Nootropics Brain Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nootropics Brain Supplements Market.

Available Customizations:

Global Nootropics Brain Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nootropics Brain Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Nootropics (Natural Nootropics, Synthetic Nootropics, Hybrid Nootropics)
  • 5.2.2. By Form (Capsules/Tablets, Powders, Liquids)
  • 5.2.3. By Ingredient Type (Racetams, Choline Sources, Herbal Extracts, Amino Acids, Others)
  • 5.2.4. By Application (Memory Enhancement, Focus and Concentration, Mood Enhancement, Energy and Alertness, Sleep Improvement, Brain Health, Longevity)
  • 5.2.5. By Sales Channel (Online Retailers, Drugstores and Pharmacies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Nootropics Brain Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Nootropics
  • 6.2.2. By Form
  • 6.2.3. By Ingredient Type
  • 6.2.4. By Application
  • 6.2.5. By Sales Channel
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nootropics Brain Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Nootropics
      • 6.3.1.2.2. By Form
      • 6.3.1.2.3. By Ingredient Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By Sales Channel
  • 6.3.2. Canada Nootropics Brain Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Nootropics
      • 6.3.2.2.2. By Form
      • 6.3.2.2.3. By Ingredient Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By Sales Channel
  • 6.3.3. Mexico Nootropics Brain Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Nootropics
      • 6.3.3.2.2. By Form
      • 6.3.3.2.3. By Ingredient Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By Sales Channel

7. Europe Nootropics Brain Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Nootropics
  • 7.2.2. By Form
  • 7.2.3. By Ingredient Type
  • 7.2.4. By Application
  • 7.2.5. By Sales Channel
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nootropics Brain Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Nootropics
      • 7.3.1.2.2. By Form
      • 7.3.1.2.3. By Ingredient Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By Sales Channel
  • 7.3.2. France Nootropics Brain Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Nootropics
      • 7.3.2.2.2. By Form
      • 7.3.2.2.3. By Ingredient Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By Sales Channel
  • 7.3.3. United Kingdom Nootropics Brain Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Nootropics
      • 7.3.3.2.2. By Form
      • 7.3.3.2.3. By Ingredient Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By Sales Channel
  • 7.3.4. Italy Nootropics Brain Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Nootropics
      • 7.3.4.2.2. By Form
      • 7.3.4.2.3. By Ingredient Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By Sales Channel
  • 7.3.5. Spain Nootropics Brain Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Nootropics
      • 7.3.5.2.2. By Form
      • 7.3.5.2.3. By Ingredient Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By Sales Channel

8. Asia Pacific Nootropics Brain Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Nootropics
  • 8.2.2. By Form
  • 8.2.3. By Ingredient Type
  • 8.2.4. By Application
  • 8.2.5. By Sales Channel
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nootropics Brain Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Nootropics
      • 8.3.1.2.2. By Form
      • 8.3.1.2.3. By Ingredient Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By Sales Channel
  • 8.3.2. India Nootropics Brain Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Nootropics
      • 8.3.2.2.2. By Form
      • 8.3.2.2.3. By Ingredient Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By Sales Channel
  • 8.3.3. Japan Nootropics Brain Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Nootropics
      • 8.3.3.2.2. By Form
      • 8.3.3.2.3. By Ingredient Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By Sales Channel
  • 8.3.4. South Korea Nootropics Brain Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Nootropics
      • 8.3.4.2.2. By Form
      • 8.3.4.2.3. By Ingredient Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By Sales Channel
  • 8.3.5. Australia Nootropics Brain Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Nootropics
      • 8.3.5.2.2. By Form
      • 8.3.5.2.3. By Ingredient Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By Sales Channel

9. Middle East & Africa Nootropics Brain Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Nootropics
  • 9.2.2. By Form
  • 9.2.3. By Ingredient Type
  • 9.2.4. By Application
  • 9.2.5. By Sales Channel
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nootropics Brain Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Nootropics
      • 9.3.1.2.2. By Form
      • 9.3.1.2.3. By Ingredient Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By Sales Channel
  • 9.3.2. UAE Nootropics Brain Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Nootropics
      • 9.3.2.2.2. By Form
      • 9.3.2.2.3. By Ingredient Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By Sales Channel
  • 9.3.3. South Africa Nootropics Brain Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Nootropics
      • 9.3.3.2.2. By Form
      • 9.3.3.2.3. By Ingredient Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By Sales Channel

10. South America Nootropics Brain Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Nootropics
  • 10.2.2. By Form
  • 10.2.3. By Ingredient Type
  • 10.2.4. By Application
  • 10.2.5. By Sales Channel
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nootropics Brain Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Nootropics
      • 10.3.1.2.2. By Form
      • 10.3.1.2.3. By Ingredient Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By Sales Channel
  • 10.3.2. Colombia Nootropics Brain Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Nootropics
      • 10.3.2.2.2. By Form
      • 10.3.2.2.3. By Ingredient Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By Sales Channel
  • 10.3.3. Argentina Nootropics Brain Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Nootropics
      • 10.3.3.2.2. By Form
      • 10.3.3.2.3. By Ingredient Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nootropics Brain Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Onnit Labs, LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Hudson Aquatic Systems LLC
• 15.3. HVMN Inc.
• 15.4. Peak Nootropics
• 15.5. Nootropics Depot
• 15.6. Pure Nootropics
• 15.7. Mind Nutrition Ltd.
• 15.8. Natural Stacks LLC
• 15.9. Nootrobox
• 15.10. Mind Lab Pro

16. Strategic Recommendations

17. About Us & Disclaimer